"Clinical trials are too slow, expensive and artificial to be the only source of evidence in 21st century medicine."
“We’re killing people. It’s costing too much… Help make it happen. Go get enraged and say ‘Change it!’”
“We can really promote innovation and a transformation of the whole culture if people are open to these new kinds of ideas."
T-Med co-founder Colin Hill presents at AHIP Institute on the personalized medicine transformation and how it drives value in healthcare interventions
Leroy Hood speaks at Yale Systems Biology Institute, who celebrates new home with ribbon cutting and symposium
Closing the Gap Now: A symposium on creating a clear pathway to accelerated and expanded access to experimental medicines for people with cancer and other deadly illnesses
UCLA Human Genetics Speaker Series: Population Genetics, Biostatistics and Bioinformatics Issues in Individualized Medicine
International Molecular Medicine Tri-Conference: Genomics & Sequencing Data Integration, Analysis and Visualization
Integrated variants from 13,000 complete genomes available to public in Kaviar database
Good policy has to be guided by good science and a systems-driven medicine that is predictive, preventive, personalized and participatory (P4). Marginal changes to evidence-based medicine (e.g., computerizing data collection) will themselves have only marginal effects on improving healthcare and reducing its costs. By Colin Hill, Leroy Hood, Sui Hang, Stuart Kauffman. (Scientific American Worldview)
Personalized medicine: Time for one-person trials
"Surviving Terminal Cancer" premieres at Lincoln Center
This documentary presents compelling evidence from doctors, regulators, and other patients that raises concern over the validity and ethical grounding of oncology research, and the resulting limitations to clinical practice. Is it possible that as a society we could make dramatic progress against cancer if we reconsidered our strategy, as opposed to blindly following a system that has failed to deliver meaningful results for over four decades? (Surviving Terminal Cancer)
Colin Hill attends President Obama's Precision Medicine Summit
"Precision medicine transcends the one-size-fits-all approach to get the right treatment to each individual patient the first time, and is transforming medicine and population health management. The result is a smarter, more impactful, and more efficient healthcare system,” says Colin Hill, GNS CEO and co-founder, and Transforming Medicine director and co-founder. (GNS Healthcare)